[Active surveillance for localized prostate cancer]

S J Drouin1, M Rouprêt, F Hamdy

  • 1Service d'Urologie Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Groupe Hospitalo-Universitaire Est, Faculté de médecine Pierre et Marie Curie, Université Paris VI, Paris, France.

Summary

Active surveillance for prostate cancer can prevent overtreatment. Current criteria suggest selecting patients with PSA<10 ng/ml and Gleason score<7 for this approach, though research is ongoing.

Related Concept Videos